Biotechnology, Science, Research, Startup, Pharmaceutical.
only save money and compress drug development timelines but will protect people in Phase I studies by more closely replicating toxicology in human tissues before a clinical trial. The ability to engineer real human tissue — with vasculature, to scale — will also reduce the number of animals used in